Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Uncovering cell-type-specific driver genes of Alzheimer's Disease by pathology-indexing scRNA-seq, spatial transcriptomics, and CRISPR screens

Award Number: R01AG074082
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/15/2022
PERIOD OF PERFORMANCE END DATE: 03/31/2027

Group Awards By:

View Award Description

Uncovering cell-type-specific driver genes of Alzheimer's Disease by pathology-indexing scRNA-seq, spatial transcriptomics, and CRISPR screens - PROJECT SUMMARY Although amyloid-β plaques and neurofibrillary tangles are the current criteria for pathologic diagnosis of Alzheimer’s Diseases (AD), only 9% of clinically diagnosed AD patients have pure AD pathology and most AD cases have mixed pathologies, which significantly increase the odds of dementia . Because diverse intra- and extracellular pathologies and stressors contribute to AD progression, it is essential to track how they affect the various cell types of the brain by cataloging cell-type-specific transcriptomic responses to both intra- and extracellular pathologies in AD pathogenesis. Therefore, this proposal aims to measure the effects of multiple pathologies on each cell type in their native environment, then make this information actionable by computationally identifying the drivers of these effects and testing them in human cell models. To this end, we propose two approaches to simultaneously measure the cell transcriptomes and multiple pathologies in millions of individual cells in their native context. The first approach, “pathology-indexing scRNA-seq,” is designed for intracellular pathologies. It combines single-cell RNA-seq (scRNA-seq) with a set of oligo- barcoded antibodies against intracellular pathologies. This approach enables us to simultaneously measure gene expression and multiple intracellular pathologies all in the same cell. The second approach, “pathology spatial transcriptomics,” is designed for extracellular pathologies. It obtains gene expression of 1~10 cells (55- μM resolution) in spatial registration with extracellular pathology. This enables us to quantify the effects of extracellular pathologies and microenvironment on cell disease states. We will apply these two innovative sequencing technologies to two brain regions, the dorsal lateral prefrontal cortex and hippocampus of postmortem brains of deeply-phenotyped ROSMAP participants. Using univariate, systems biology, and deep learning computational methods, we will identify candidate genes that drive cell-type-specific disease states. To test predicted early driver genes and provide therapeutic targets, we will conduct CRISPR screens in human cortical cell models derived from control and AD isogenic iPSC lines. Collectively, our study will shed important light on the cell-type-specific driver genes in AD pathogenesis, define molecular pathways leading to cell disease-states, and provide experimentally validated targets for preventing the disease-state transition during early AD development.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $710,201 )
2025	2025	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	000	4	3/25/2025	NON-COMPETING CONTINUATION	$652,226
2025	2025	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	001	4	6/18/2025	NON-COMPETING CONTINUATION	$57,975
														Subtotal = $710,201

Issue Date FY: 2024 ( Subtotal = $718,503 )
2024	2024	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	000	3	4/17/2024	NON-COMPETING CONTINUATION	$718,503
														Subtotal = $718,503

Issue Date FY: 2023 ( Subtotal = $744,180 )
2023	2023	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	000	2	4/11/2023	NON-COMPETING CONTINUATION	$744,180
														Subtotal = $744,180

Issue Date FY: 2022 ( Subtotal = $766,665 )
2022	2022	RUSH UNIVERSITY MEDICAL CENTER	1620 W HARRISON ST	CHICAGO	IL	60612	COOK	USA	Aging Research	000	1	4/7/2022	NEW	$766,665
														Subtotal = $766,665

Grand Total All Awards = $2,939,549

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Uncovering cell-type-specific driver genes of Alzheimer's Disease by pathology-indexing scRNA-seq, spatial transcriptomics, and CRISPR screens

Award Number: R01AG074082

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/15/2022

PERIOD OF PERFORMANCE END DATE: 03/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer